Immune Cells at Injury Sites Release Opioid Peptides That Naturally Control Inflammatory Pain

Immune cells infiltrating inflamed tissue release met-enkephalin and dynorphin A (in addition to previously known beta-endorphin), providing a local opioid pain control system at sites of inflammation.

Cabot, Peter J et al.·Pain·2001·Moderate EvidenceAnimal StudyAnimal Study
RPEP-00653Animal StudyModerate Evidence2001RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Animal Study
Evidence
Moderate Evidence
Sample
Not reported

What This Study Found

Immune cells at sites of inflammation contain and release met-enkephalin, dynorphin A, and beta-endorphin, which activate peripheral opioid receptors on sensory nerves to provide local inflammatory pain control.

Key Numbers

How They Did This

Animal study in rats with CFA-induced paw inflammation. Immune cells from inflamed tissue tested for opioid peptide content (RIA) and release (stimulation assays). Pain behavior correlated with local opioid receptor activation.

Why This Research Matters

Local pain control by immune cells avoids the side effects of brain-acting painkillers. Enhancing this natural peripheral opioid system could provide effective pain relief without sedation, addiction, or respiratory depression.

The Bigger Picture

The immune system doesn't just cause pain through inflammation — it also provides pain relief through local opioid release. This elegant self-regulating system could be harnessed for novel pain treatments.

What This Study Doesn't Tell Us

Rat inflammation model. The quantity of opioid released may not be sufficient for complete pain control. Human immune cell opioid release may differ quantitatively.

Questions This Raises

  • ?Can immune cell opioid release be pharmacologically enhanced for pain management?
  • ?Do anti-inflammatory drugs interfere with this natural pain control?
  • ?Is this mechanism impaired in chronic pain conditions?

Trust & Context

Key Stat:
3 local painkillers Immune cells release met-enkephalin, dynorphin A, and beta-endorphin directly at inflammation sites for targeted, local pain control
Evidence Grade:
Moderate evidence from a well-designed inflammatory pain model with specific peptide quantification and functional pain behavior correlation.
Study Age:
Published in 2001. Peripheral immune cell opioid release is now recognized as a key component of inflammatory pain regulation.
Original Title:
Methionine-enkephalin-and Dynorphin A-release from immune cells and control of inflammatory pain.
Published In:
Pain, 93(3), 207-212 (2001)
Database ID:
RPEP-00653

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / Observational
Case Report / Animal StudyOne case or non-human subjects
This study

Tests effects in animals (usually mice or rats), not humans.

What do these levels mean? →

Frequently Asked Questions

Do your immune cells make painkillers?

Yes. When immune cells arrive at an inflammation site, they release the same natural opioid peptides found in the brain — but locally at the site of pain, providing targeted relief without brain-related side effects.

Could this be used for better pain treatment?

Yes. Drugs that boost this local opioid release could control pain at its source without the sedation, addiction, and respiratory risks of conventional opioids. This is an active area of pain research.

Read More on RethinkPeptides

Cite This Study

RPEP-00653·https://rethinkpeptides.com/research/RPEP-00653

APA

Cabot, Peter J; Carter, Laurenda; Schäfer, Michael; Stein, Christoph. (2001). Methionine-enkephalin-and Dynorphin A-release from immune cells and control of inflammatory pain.. Pain, 93(3), 207-212. https://doi.org/10.1016/S0304-3959(01)00322-0

MLA

Cabot, Peter J, et al. "Methionine-enkephalin-and Dynorphin A-release from immune cells and control of inflammatory pain.." Pain, 2001. https://doi.org/10.1016/S0304-3959(01)00322-0

RethinkPeptides

RethinkPeptides Research Database. "Methionine-enkephalin-and Dynorphin A-release from immune ce..." RPEP-00653. Retrieved from https://rethinkpeptides.com/research/cabot-2001-methionineenkephalinand-dynorphin-arelease-from

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.